Ellume -Patented Platform Technology
Our patented detection method uses unique fluorescent nanoparticles and a sophisticated reader system to achieve accurate results from a clinical sample within minutes. We create efficiencies using our platform technology across a range of diagnostic tests for consumers, healthcare professionals at the point-of-care and higher-throughput laboratories. Our strategy of using digital technology at the core of our products has enabled us to create better ways to diagnose illness, control disease and link to optimal therapy.
Our self-test uses a Bluetooth® connected analyzer with the user’s smartphone to analyze a self-collected nasal sample.
Through a secure cloud connection, Ellume’s tests can provide real time reporting of test results to all State Departments, the CDC, employers, educators and healthcare professionals, for efficient disease mapping.